chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Pyrexia, Vaccination site discolouration, Vaccination site joint swelling
Clinical narrative: injection site pain; tiredness; headache; muscle pain; chills; joint paint; joint paint; injection site swelling; injection site was very red; nausea; nausea; super tired; arm pain in my right arm same spot from injection on left arm; This is a spontaneous report received from a contactable female consumer reported for herself that:  A 49-years-old female patient (non-pregnant) received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Ff2587), via an unspecified route of administration, administered in Arm Left on 20Sep2021 (At the age of 49 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included armour thyroid 90mg taken for an unspecified indication, start and stop date were not reported. The patient had allergy to levothyroxine, synthetic thyroid and Synthroid. On 20Sep2021, the patient experienced injection site pain, tiredness, headache, muscle pain, chills, joint paint, injection site swelling, injection site was very red, nausea, blurred vision for 3 days, super tired, pain in the right arm same spot from injection on left arm. No treatment was received in response to the adverse events. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. At the time of reporting, the outcome of the events were recovering.    Follow-up attempts are completed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vision blurred
Clinical narrative: injection site pain; tiredness; headache; muscle pain; chills; joint paint; joint paint; injection site swelling; injection site was very red; nausea; nausea; super tired; arm pain in my right arm same spot from injection on left arm; This is a spontaneous report received from a contactable female consumer reported for herself that:  A 49-years-old female patient (non-pregnant) received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Ff2587), via an unspecified route of administration, administered in Arm Left on 20Sep2021 (At the age of 49 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included armour thyroid 90mg taken for an unspecified indication, start and stop date were not reported. The patient had allergy to levothyroxine, synthetic thyroid and Synthroid. On 20Sep2021, the patient experienced injection site pain, tiredness, headache, muscle pain, chills, joint paint, injection site swelling, injection site was very red, nausea, blurred vision for 3 days, super tired, pain in the right arm same spot from injection on left arm. No treatment was received in response to the adverse events. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. At the time of reporting, the outcome of the events were recovering.    Follow-up attempts are completed. No further information is expected.
Age: 51.0
Sex: U
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pyrexia
Clinical narrative: low grade temp; fatigue; chilly; This is a spontaneous report from a non-contactable consumer (patient). A 51-years-old patient of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EN6204), via intramuscular route of administration in the left arm on 04Mar2021 at 09:00 as dose 2, single for COVID-19 immunization (at the age of 51-years-old). The patient medical history and concomitant medications were not reported. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EN6201), via intramuscular route of administration in the left arm on 11Feb2021 at 09:00 as dose 2, single for COVID-19 immunization (at the age of 51-years-old) and experienced loss of smell test, fatigue and injection site pain. The patient experienced chilly on 04Mar2021 23:00, low grade temp, fatigue on 05Mar2021. The clinical outcome for the events was unknown.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Angina pectoris, Heart rate, Heart rate increased, Painful respiration
Clinical narrative: Pain in chest, around the heart; Sharp and sudden pains, may happen while breathing occasionally.; Elevated heart rate for the first couple of days after shot; This is a spontaneous report from a non-contactable consumer (patient).  A 22-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in the left arm in Sep2021 (Batch/Lot Number: FC3180) as DOSE 1, SINGLE for COVID-19 immunisation.  Medical history included asthma from an unknown date and unknown if ongoing.  There were no concomitant medications.  The patient previously took amoxicillin and experienced allergies. Vaccine was received in a pharmacy/ drug store. There were no other vaccine received in four weeks and no other medications received in two weeks. The patient did not have COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination.  On 16Sep2021, the patient experienced pain in chest, around the heart (medically significant), sharp and sudden pains, may happen while breathing occasionally, and elevated heart rate for the first couple of days after shot. The pain persisted up until the date of the report. The events resulted in doctor or other healthcare professional office/clinic visit. The events did not require treatment. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Asthenia, Balance disorder, Blister, Blood pressure increased
Clinical narrative: had pains throughout her body; Funny feeling in chest; abdominal pain; elevated blood pressure; not take a deep breath; felt dizziness; a bitter taste in mouth; weakness; could hardly walk; felt unbalanced; nausea; blurred vision; chills; blisters on her tongue; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received bnt162b2 (COMIRNATY, Lot Number: FC3181), Dose 1 via an unspecified route of administration, administered in the right arm on 15Sep2021 at 09:18 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included covid-19 from 2020 to an unknown date (she had covid last Oct/Nov2020), nervous system disorder from an unknown date and unknown if ongoing , respiratory distress from Nov1999 to Nov1999 , multiple sclerosis from Nov1999 and ongoing , blister from an unknown date and unknown if ongoing This is what happened when she had covid last Oct/Nov2020. The patient's concomitant medications were not reported. On 15Sep2021, the patient experienced elevated blood pressure (medically significant), not take a deep breath, felt dizziness, a bitter taste in mouth, weakness, could hardly walk, felt unbalanced, nausea, blurred vision, chills, blisters on her tongue, funny feeling in chest, and abdominal pain. On an unknown date, the patient had pains throughout her body. The patient underwent lab tests and procedures which included blood pressure measurement: 186/86 on 15Sep2021. The patient recovered from the events, a bitter taste in mouth and chills. The patient had not recovered from the events, elevated blood pressure, not take a deep breath, felt dizziness, felt dizziness, weakness, could hardly walk, felt unbalanced, nausea, blurred vision, had pains throughout her body, blisters on her tongue, funny feeling in chest, and abdominal pain.   Follow-up attempts are completed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Chest discomfort, Chills, Dizziness, Dysgeusia
Clinical narrative: had pains throughout her body; Funny feeling in chest; abdominal pain; elevated blood pressure; not take a deep breath; felt dizziness; a bitter taste in mouth; weakness; could hardly walk; felt unbalanced; nausea; blurred vision; chills; blisters on her tongue; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received bnt162b2 (COMIRNATY, Lot Number: FC3181), Dose 1 via an unspecified route of administration, administered in the right arm on 15Sep2021 at 09:18 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included covid-19 from 2020 to an unknown date (she had covid last Oct/Nov2020), nervous system disorder from an unknown date and unknown if ongoing , respiratory distress from Nov1999 to Nov1999 , multiple sclerosis from Nov1999 and ongoing , blister from an unknown date and unknown if ongoing This is what happened when she had covid last Oct/Nov2020. The patient's concomitant medications were not reported. On 15Sep2021, the patient experienced elevated blood pressure (medically significant), not take a deep breath, felt dizziness, a bitter taste in mouth, weakness, could hardly walk, felt unbalanced, nausea, blurred vision, chills, blisters on her tongue, funny feeling in chest, and abdominal pain. On an unknown date, the patient had pains throughout her body. The patient underwent lab tests and procedures which included blood pressure measurement: 186/86 on 15Sep2021. The patient recovered from the events, a bitter taste in mouth and chills. The patient had not recovered from the events, elevated blood pressure, not take a deep breath, felt dizziness, felt dizziness, weakness, could hardly walk, felt unbalanced, nausea, blurred vision, had pains throughout her body, blisters on her tongue, funny feeling in chest, and abdominal pain.   Follow-up attempts are completed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Gait disturbance, Nausea, Pain, Vision blurred
Clinical narrative: had pains throughout her body; Funny feeling in chest; abdominal pain; elevated blood pressure; not take a deep breath; felt dizziness; a bitter taste in mouth; weakness; could hardly walk; felt unbalanced; nausea; blurred vision; chills; blisters on her tongue; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received bnt162b2 (COMIRNATY, Lot Number: FC3181), Dose 1 via an unspecified route of administration, administered in the right arm on 15Sep2021 at 09:18 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included covid-19 from 2020 to an unknown date (she had covid last Oct/Nov2020), nervous system disorder from an unknown date and unknown if ongoing , respiratory distress from Nov1999 to Nov1999 , multiple sclerosis from Nov1999 and ongoing , blister from an unknown date and unknown if ongoing This is what happened when she had covid last Oct/Nov2020. The patient's concomitant medications were not reported. On 15Sep2021, the patient experienced elevated blood pressure (medically significant), not take a deep breath, felt dizziness, a bitter taste in mouth, weakness, could hardly walk, felt unbalanced, nausea, blurred vision, chills, blisters on her tongue, funny feeling in chest, and abdominal pain. On an unknown date, the patient had pains throughout her body. The patient underwent lab tests and procedures which included blood pressure measurement: 186/86 on 15Sep2021. The patient recovered from the events, a bitter taste in mouth and chills. The patient had not recovered from the events, elevated blood pressure, not take a deep breath, felt dizziness, felt dizziness, weakness, could hardly walk, felt unbalanced, nausea, blurred vision, had pains throughout her body, blisters on her tongue, funny feeling in chest, and abdominal pain.   Follow-up attempts are completed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Abortion spontaneous, Cardiac disorder, Diarrhoea, Gait disturbance, Illness
Clinical narrative: she found out an aborted baby in her body as she is struggling to walk; struggling to walk; got so sick; not felt well/has not been well; diarrhea; swollen lymph nodes; feels like her "heart hiccups"/"beating against a fluid sack"; feels like she has fluid on her heart when she lays down/goes to bed; This is a spontaneous report from a contactable consumer (patient). A 59-year-old pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 20Aug2021 (Batch/Lot Number: FC3182, Expiry date: unknown) (at the age of 58-years-old) as dose 2, single for COVID-19 immunisation. Vaccination facility type was pharmacy/drug store. The patient was pregnant at time of vaccination. Medical history included multiple sclerosis diagnosed in 1991 and ongoing. There were no concomitant medications. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 27Jul2021 (Batch/Lot Number: FA7484) (at the age of 58-years-old) as dose 1, single for COVID-19 immunisation and experienced maternal vaccine exposure. The patient stated that she got so sick, has not felt well/has not been well since the second dose and has had diarrhea ever since and swollen lymph nodes on unspecified date in Aug2021. She further stated that it feels like her "heart hiccups", feels like she has fluid on her heart when she lays down/goes to bed and feels like it is "beating against a fluid sack" and this has been ongoing since vaccination. But now (in Oct2021), she found out an aborted baby in her body as she is struggling to walk (as reported). She stated she read this when she went to Pfizer research. She does have MS (Multiple Sclerosis) and is unable to determine if it is related to that. Patient stated she is pro-life and wanted to know if there are aborted babies in the vaccines. She stated her husband got Moderna and she got the Pfizer vaccine. She stated that she also sees a nurse practitioner. After vaccination, she was given a factsheet that stated that the vaccine may not protect everyone, and she would like to know why. She would like information on booster doses of Pfizer Covid 19 vaccine and would like to know if she should receive Ivermectin. The patient was referred to provider for further consultation and medical advice. The outcome of all the events was not recovered, except for abortion spontaneous and struggling to walk which was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Malaise, Palpitations
Clinical narrative: she found out an aborted baby in her body as she is struggling to walk; struggling to walk; got so sick; not felt well/has not been well; diarrhea; swollen lymph nodes; feels like her "heart hiccups"/"beating against a fluid sack"; feels like she has fluid on her heart when she lays down/goes to bed; This is a spontaneous report from a contactable consumer (patient). A 59-year-old pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 20Aug2021 (Batch/Lot Number: FC3182, Expiry date: unknown) (at the age of 58-years-old) as dose 2, single for COVID-19 immunisation. Vaccination facility type was pharmacy/drug store. The patient was pregnant at time of vaccination. Medical history included multiple sclerosis diagnosed in 1991 and ongoing. There were no concomitant medications. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 27Jul2021 (Batch/Lot Number: FA7484) (at the age of 58-years-old) as dose 1, single for COVID-19 immunisation and experienced maternal vaccine exposure. The patient stated that she got so sick, has not felt well/has not been well since the second dose and has had diarrhea ever since and swollen lymph nodes on unspecified date in Aug2021. She further stated that it feels like her "heart hiccups", feels like she has fluid on her heart when she lays down/goes to bed and feels like it is "beating against a fluid sack" and this has been ongoing since vaccination. But now (in Oct2021), she found out an aborted baby in her body as she is struggling to walk (as reported). She stated she read this when she went to Pfizer research. She does have MS (Multiple Sclerosis) and is unable to determine if it is related to that. Patient stated she is pro-life and wanted to know if there are aborted babies in the vaccines. She stated her husband got Moderna and she got the Pfizer vaccine. She stated that she also sees a nurse practitioner. After vaccination, she was given a factsheet that stated that the vaccine may not protect everyone, and she would like to know why. She would like information on booster doses of Pfizer Covid 19 vaccine and would like to know if she should receive Ivermectin. The patient was referred to provider for further consultation and medical advice. The outcome of all the events was not recovered, except for abortion spontaneous and struggling to walk which was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Hallucination, auditory, SARS-CoV-2 test
Clinical narrative: Auditory hallucinations (hearing voices); This is a spontaneous report from a contactable consumer (patient). A 26-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 at the age of 26-years-old via an unspecified route of administration, administered in Arm Right on 09Apr2021 (Batch/Lot Number: EW0158) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. Concomitant medications included amfetamine aspartate monohydrate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (MYDAYIS); quetiapine fumarate (SEROQUEL); levetiracetam (KEPPRA); amlodipine maleate, valsartan (AMLODIPINE-VALSARTAN) all taken for an unspecified indication, start and stop date were not reported. The patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration administered in arm left on 19Mar2021 (Batch/Lot No: EP7534) for covid-19 immunisation at the age of 26-years-old. The patient experienced auditory hallucinations (hearing voices) on 09Jun2021 and was hospitalized due to the event. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 10Jun2021 Post vaccination. The patient received dose 3 via an unspecified route of administration, administered in Arm Left on 27Sep2021 (Batch/Lot Number: FF2588) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. The patient did not recover from the event.   Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Pain, Swelling
Clinical narrative: he could barely walk because it had caused so much pain and swelling after he received the shot.; he could barely walk because it had caused so much pain and swelling after he received the shot.; he could barely walk because it had caused so much pain and swelling after he received the shot.; This is a spontaneous report from a contactable consumer. This consumer reported same events for two patients. This is one of the two reports.  A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 2, single for covid-19 immunisation. Medical history included back surgery 20 years ago (2001). The patient's concomitant medications were not reported. The patient had the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date for Covid-19 immunization. The reporter stated that the patient in the same physical therapy as she (reporter) was had the same thing happened. The patient had gotten his second Pfizer shot and he had had back surgery 20 years ago; he could barely walk because it had caused so much pain and swelling after he received the shot. The patient had to get epidurals. The outcome of the events was unknown.  The lot number for BNT162B2 was not provided and will be requested during follow-up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101363269 same reporter/drug/events, different patient
Sex: U
Vaccine: COVID19
Symptoms: Gait disturbance, Pain, Swelling
Clinical narrative: he could barely walk because it had caused so much pain and swelling after he received the shot/same thing happened with my moms neighbor; he could barely walk because it had caused so much pain and swelling after he received the shot/same thing happened with my moms neighbor; he could barely walk because it had caused so much pain and swelling after he received the shot/same thing happened with my moms neighbor; This is a spontaneous report from a contactable consumer. This consumer reported same events for two patients. This is one of the two reports.  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The reporter stated that there was a man in physical therapy at the same time she (reporter) was. The man had gotten his second Pfizer shot. He could barely walk because it had caused so much pain and swelling after he received the shot. The same thing happened with this patient (reporter's mom's neighbor) and they both (man and this patient) had to get epidurals. The outcome of the events was unknown.  The lot number for BNT162B2 was not provided and will be requested during follow-up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101363148 same reporter/drug/events, different patient
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Thrombosis
Clinical narrative: Almost died; Blood clots; This is a spontaneous report from a Pfizer-sponsored program received from a non-contactable consumer. A female patient of an unspecified age received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced almost died and blood clots. It was further reported that the reporter wanted to know if the vaccine has been FDA approved and what are the difference between the 2 vaccines (not specified). She also mentioned that a friend had gotten blood clots after getting the vaccine and she almost died. The reporter also inquired what myocarditis and pericarditis are. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Appendicitis, Body temperature, Pyrexia
Clinical narrative: Had my appendix removed and a right hemicolectomy to remove highly inflamed and infected tissue; abdominal pain/ pain localized to the lower right quadrant of my abdomen; fever; This is a spontaneous report from a contactable consumer (patient herself). A 50-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), dose 1 via an unspecified route of administration, administered in Arm Left, Age at Vaccination: 50 Years, on 22Jan2021 10:15 (Batch/Lot Number: EL1283) as DOSE 1, SINGLE for COVID-19 immunisation. The patient's medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 04Feb2021, On day 8 pain localized to the lower right quadrant of her abdomen and she ran a fever, also reported as 13 days after her first vaccination dose, patient began to experience abdominal pain. Patient went to the emergency room on an unspecified date in 2021. Patient had her appendix removed and a right hemicolectomy to remove highly inflamed and infected tissue. Patient was hospitalized for 5 days on unspecified date in 2021. The adverse event resulted in emergency room/department or urgent care. Facility where the most recent COVID-19 vaccine was administered: Hospital. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovered in 2021. Seriousness criteria-Caused/prolonged hospitalization. Patient had her second dose of Pfizer COVID-19 vaccine on 12Feb2021 at 11:00 AM in the left arm for COVID-19 immunisation.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alopecia, Arthritis, COVID-19, Fatigue, Haemoglobin abnormal
Clinical narrative: covid test result Positive; covid test result Positive; joint inflammation; joint inflammation and swelling; extreme hairloss; hemoglobin leakage under skin; intermittent fever; intermittent body rash; extreme itching and/or burning of skin; burning of skin; Fatigue; This is a spontaneous report from a contactable nurse (patient). A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), 1st single dose via an unspecified route of administration in the arm left on 14Jan2021 at 12:15 PM (LOT number: EL3248, expiration date unknown) and 2nd single dose via an unspecified route of administration in the arm left on 10Feb2021 at 12:00 PM (LOT/Batch number and expiration date unknown) for COVID-19 immunization. Patient was 69-year-old at time of vaccination. Patient was not pregnant at time of vaccination and events onset. Medical history included previous breast CA from 1993. Concomitant medications the patient received within 2 weeks of vaccination included losartan, hydrochlorothiazide.  The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. After dose 1, patient had joint inflammation leading to severe joint inflammation and swelling for 12 wks/5 days then extreme hairloss, severe reaction to bee sting and amoxicillin, severe allergic response to foods, histamine and any sugar, hemoglobin leakage under skin, intermittent fever, intermittent body rash, extreme itching and/or burning of skin, fatigue; on 19Jan2021 at 12:00 and were still ongoing. Patient received treatment for above events. Patient had previous covid test (Blood test) on 28Sep2021 which was positive. Test to R/O other things (Blood test) on 28Sep2021 was negative. The events resulted in doctor or other healthcare professional office/clinic visit. "US lower extremities, steroid rash, many visits" was reported as treatment for the events. Outcome of event COVID test result Positive was unknown, of the other events was not recovered.  Information on the lot/batch number of 2nd dose has been requested.; Sender's Comments: The possibility of COVID-19, Vaccination failure being an intercurrent condition cannot be ruled out. The response to the vaccine can vary from one person to another and hence the occurrence of the event post vaccination cannot be completely ruled out.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Investigation, Joint swelling, Pruritus, Pyrexia, Rash
Clinical narrative: covid test result Positive; covid test result Positive; joint inflammation; joint inflammation and swelling; extreme hairloss; hemoglobin leakage under skin; intermittent fever; intermittent body rash; extreme itching and/or burning of skin; burning of skin; Fatigue; This is a spontaneous report from a contactable nurse (patient). A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), 1st single dose via an unspecified route of administration in the arm left on 14Jan2021 at 12:15 PM (LOT number: EL3248, expiration date unknown) and 2nd single dose via an unspecified route of administration in the arm left on 10Feb2021 at 12:00 PM (LOT/Batch number and expiration date unknown) for COVID-19 immunization. Patient was 69-year-old at time of vaccination. Patient was not pregnant at time of vaccination and events onset. Medical history included previous breast CA from 1993. Concomitant medications the patient received within 2 weeks of vaccination included losartan, hydrochlorothiazide.  The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. After dose 1, patient had joint inflammation leading to severe joint inflammation and swelling for 12 wks/5 days then extreme hairloss, severe reaction to bee sting and amoxicillin, severe allergic response to foods, histamine and any sugar, hemoglobin leakage under skin, intermittent fever, intermittent body rash, extreme itching and/or burning of skin, fatigue; on 19Jan2021 at 12:00 and were still ongoing. Patient received treatment for above events. Patient had previous covid test (Blood test) on 28Sep2021 which was positive. Test to R/O other things (Blood test) on 28Sep2021 was negative. The events resulted in doctor or other healthcare professional office/clinic visit. "US lower extremities, steroid rash, many visits" was reported as treatment for the events. Outcome of event COVID test result Positive was unknown, of the other events was not recovered.  Information on the lot/batch number of 2nd dose has been requested.; Sender's Comments: The possibility of COVID-19, Vaccination failure being an intercurrent condition cannot be ruled out. The response to the vaccine can vary from one person to another and hence the occurrence of the event post vaccination cannot be completely ruled out.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test, Skin burning sensation, Vaccination failure
Clinical narrative: covid test result Positive; covid test result Positive; joint inflammation; joint inflammation and swelling; extreme hairloss; hemoglobin leakage under skin; intermittent fever; intermittent body rash; extreme itching and/or burning of skin; burning of skin; Fatigue; This is a spontaneous report from a contactable nurse (patient). A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), 1st single dose via an unspecified route of administration in the arm left on 14Jan2021 at 12:15 PM (LOT number: EL3248, expiration date unknown) and 2nd single dose via an unspecified route of administration in the arm left on 10Feb2021 at 12:00 PM (LOT/Batch number and expiration date unknown) for COVID-19 immunization. Patient was 69-year-old at time of vaccination. Patient was not pregnant at time of vaccination and events onset. Medical history included previous breast CA from 1993. Concomitant medications the patient received within 2 weeks of vaccination included losartan, hydrochlorothiazide.  The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. After dose 1, patient had joint inflammation leading to severe joint inflammation and swelling for 12 wks/5 days then extreme hairloss, severe reaction to bee sting and amoxicillin, severe allergic response to foods, histamine and any sugar, hemoglobin leakage under skin, intermittent fever, intermittent body rash, extreme itching and/or burning of skin, fatigue; on 19Jan2021 at 12:00 and were still ongoing. Patient received treatment for above events. Patient had previous covid test (Blood test) on 28Sep2021 which was positive. Test to R/O other things (Blood test) on 28Sep2021 was negative. The events resulted in doctor or other healthcare professional office/clinic visit. "US lower extremities, steroid rash, many visits" was reported as treatment for the events. Outcome of event COVID test result Positive was unknown, of the other events was not recovered.  Information on the lot/batch number of 2nd dose has been requested.; Sender's Comments: The possibility of COVID-19, Vaccination failure being an intercurrent condition cannot be ruled out. The response to the vaccine can vary from one person to another and hence the occurrence of the event post vaccination cannot be completely ruled out.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alanine aminotransferase, Alopecia, Anion gap, Arthralgia, Aspartate aminotransferase
Clinical narrative: covid test result Positive; covid test result Positive; joint inflammation; joint inflammation and swelling; extreme hairloss; hemoglobin leakage under skin; intermittent fever; intermittent body rash; extreme itching and/or burning of skin; burning of skin; Fatigue; This is a spontaneous report from a contactable nurse (patient). A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), 1st single dose via an unspecified route of administration in the arm left on 14Jan2021 at 12:15 PM (LOT number: EL3248, expiration date unknown) and 2nd single dose via an unspecified route of administration in the arm left on 10Feb2021 at 12:00 PM (LOT/Batch number and expiration date unknown) for COVID-19 immunization. Patient was 69-year-old at time of vaccination. Patient was not pregnant at time of vaccination and events onset. Medical history included previous breast CA from 1993. Concomitant medications the patient received within 2 weeks of vaccination included losartan, hydrochlorothiazide.  The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. After dose 1, patient had joint inflammation leading to severe joint inflammation and swelling for 12 wks/5 days then extreme hairloss, severe reaction to bee sting and amoxicillin, severe allergic response to foods, histamine and any sugar, hemoglobin leakage under skin, intermittent fever, intermittent body rash, extreme itching and/or burning of skin, fatigue; on 19Jan2021 at 12:00 and were still ongoing. Patient received treatment for above events. Patient had previous covid test (Blood test) on 28Sep2021 which was positive. Test to R/O other things (Blood test) on 28Sep2021 was negative. The events resulted in doctor or other healthcare professional office/clinic visit. "US lower extremities, steroid rash, many visits" was reported as treatment for the events. Outcome of event COVID test result Positive was unknown, of the other events was not recovered.  Information on the lot/batch number of 2nd dose has been requested.; Sender's Comments: The possibility of COVID-19, Vaccination failure being an intercurrent condition cannot be ruled out. The response to the vaccine can vary from one person to another and hence the occurrence of the event post vaccination cannot be completely ruled out.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood albumin, Blood alkaline phosphatase, Blood bilirubin, Blood calcium, Blood chloride
Clinical narrative: covid test result Positive; covid test result Positive; joint inflammation; joint inflammation and swelling; extreme hairloss; hemoglobin leakage under skin; intermittent fever; intermittent body rash; extreme itching and/or burning of skin; burning of skin; Fatigue; This is a spontaneous report from a contactable nurse (patient). A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), 1st single dose via an unspecified route of administration in the arm left on 14Jan2021 at 12:15 PM (LOT number: EL3248, expiration date unknown) and 2nd single dose via an unspecified route of administration in the arm left on 10Feb2021 at 12:00 PM (LOT/Batch number and expiration date unknown) for COVID-19 immunization. Patient was 69-year-old at time of vaccination. Patient was not pregnant at time of vaccination and events onset. Medical history included previous breast CA from 1993. Concomitant medications the patient received within 2 weeks of vaccination included losartan, hydrochlorothiazide.  The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. After dose 1, patient had joint inflammation leading to severe joint inflammation and swelling for 12 wks/5 days then extreme hairloss, severe reaction to bee sting and amoxicillin, severe allergic response to foods, histamine and any sugar, hemoglobin leakage under skin, intermittent fever, intermittent body rash, extreme itching and/or burning of skin, fatigue; on 19Jan2021 at 12:00 and were still ongoing. Patient received treatment for above events. Patient had previous covid test (Blood test) on 28Sep2021 which was positive. Test to R/O other things (Blood test) on 28Sep2021 was negative. The events resulted in doctor or other healthcare professional office/clinic visit. "US lower extremities, steroid rash, many visits" was reported as treatment for the events. Outcome of event COVID test result Positive was unknown, of the other events was not recovered.  Information on the lot/batch number of 2nd dose has been requested.; Sender's Comments: The possibility of COVID-19, Vaccination failure being an intercurrent condition cannot be ruled out. The response to the vaccine can vary from one person to another and hence the occurrence of the event post vaccination cannot be completely ruled out.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood creatinine, Blood glucose, Blood potassium, Blood pressure measurement, Blood sodium
Clinical narrative: covid test result Positive; covid test result Positive; joint inflammation; joint inflammation and swelling; extreme hairloss; hemoglobin leakage under skin; intermittent fever; intermittent body rash; extreme itching and/or burning of skin; burning of skin; Fatigue; This is a spontaneous report from a contactable nurse (patient). A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), 1st single dose via an unspecified route of administration in the arm left on 14Jan2021 at 12:15 PM (LOT number: EL3248, expiration date unknown) and 2nd single dose via an unspecified route of administration in the arm left on 10Feb2021 at 12:00 PM (LOT/Batch number and expiration date unknown) for COVID-19 immunization. Patient was 69-year-old at time of vaccination. Patient was not pregnant at time of vaccination and events onset. Medical history included previous breast CA from 1993. Concomitant medications the patient received within 2 weeks of vaccination included losartan, hydrochlorothiazide.  The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. After dose 1, patient had joint inflammation leading to severe joint inflammation and swelling for 12 wks/5 days then extreme hairloss, severe reaction to bee sting and amoxicillin, severe allergic response to foods, histamine and any sugar, hemoglobin leakage under skin, intermittent fever, intermittent body rash, extreme itching and/or burning of skin, fatigue; on 19Jan2021 at 12:00 and were still ongoing. Patient received treatment for above events. Patient had previous covid test (Blood test) on 28Sep2021 which was positive. Test to R/O other things (Blood test) on 28Sep2021 was negative. The events resulted in doctor or other healthcare professional office/clinic visit. "US lower extremities, steroid rash, many visits" was reported as treatment for the events. Outcome of event COVID test result Positive was unknown, of the other events was not recovered.  Information on the lot/batch number of 2nd dose has been requested.; Sender's Comments: The possibility of COVID-19, Vaccination failure being an intercurrent condition cannot be ruled out. The response to the vaccine can vary from one person to another and hence the occurrence of the event post vaccination cannot be completely ruled out.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Blood urea, Blood uric acid, C-reactive protein, Carbon dioxide
Clinical narrative: covid test result Positive; covid test result Positive; joint inflammation; joint inflammation and swelling; extreme hairloss; hemoglobin leakage under skin; intermittent fever; intermittent body rash; extreme itching and/or burning of skin; burning of skin; Fatigue; This is a spontaneous report from a contactable nurse (patient). A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), 1st single dose via an unspecified route of administration in the arm left on 14Jan2021 at 12:15 PM (LOT number: EL3248, expiration date unknown) and 2nd single dose via an unspecified route of administration in the arm left on 10Feb2021 at 12:00 PM (LOT/Batch number and expiration date unknown) for COVID-19 immunization. Patient was 69-year-old at time of vaccination. Patient was not pregnant at time of vaccination and events onset. Medical history included previous breast CA from 1993. Concomitant medications the patient received within 2 weeks of vaccination included losartan, hydrochlorothiazide.  The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. After dose 1, patient had joint inflammation leading to severe joint inflammation and swelling for 12 wks/5 days then extreme hairloss, severe reaction to bee sting and amoxicillin, severe allergic response to foods, histamine and any sugar, hemoglobin leakage under skin, intermittent fever, intermittent body rash, extreme itching and/or burning of skin, fatigue; on 19Jan2021 at 12:00 and were still ongoing. Patient received treatment for above events. Patient had previous covid test (Blood test) on 28Sep2021 which was positive. Test to R/O other things (Blood test) on 28Sep2021 was negative. The events resulted in doctor or other healthcare professional office/clinic visit. "US lower extremities, steroid rash, many visits" was reported as treatment for the events. Outcome of event COVID test result Positive was unknown, of the other events was not recovered.  Information on the lot/batch number of 2nd dose has been requested.; Sender's Comments: The possibility of COVID-19, Vaccination failure being an intercurrent condition cannot be ruled out. The response to the vaccine can vary from one person to another and hence the occurrence of the event post vaccination cannot be completely ruled out.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Complement factor C3, Complement factor C4, Dizziness, Double stranded DNA antibody, EGFR status assay
Clinical narrative: covid test result Positive; covid test result Positive; joint inflammation; joint inflammation and swelling; extreme hairloss; hemoglobin leakage under skin; intermittent fever; intermittent body rash; extreme itching and/or burning of skin; burning of skin; Fatigue; This is a spontaneous report from a contactable nurse (patient). A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), 1st single dose via an unspecified route of administration in the arm left on 14Jan2021 at 12:15 PM (LOT number: EL3248, expiration date unknown) and 2nd single dose via an unspecified route of administration in the arm left on 10Feb2021 at 12:00 PM (LOT/Batch number and expiration date unknown) for COVID-19 immunization. Patient was 69-year-old at time of vaccination. Patient was not pregnant at time of vaccination and events onset. Medical history included previous breast CA from 1993. Concomitant medications the patient received within 2 weeks of vaccination included losartan, hydrochlorothiazide.  The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. After dose 1, patient had joint inflammation leading to severe joint inflammation and swelling for 12 wks/5 days then extreme hairloss, severe reaction to bee sting and amoxicillin, severe allergic response to foods, histamine and any sugar, hemoglobin leakage under skin, intermittent fever, intermittent body rash, extreme itching and/or burning of skin, fatigue; on 19Jan2021 at 12:00 and were still ongoing. Patient received treatment for above events. Patient had previous covid test (Blood test) on 28Sep2021 which was positive. Test to R/O other things (Blood test) on 28Sep2021 was negative. The events resulted in doctor or other healthcare professional office/clinic visit. "US lower extremities, steroid rash, many visits" was reported as treatment for the events. Outcome of event COVID test result Positive was unknown, of the other events was not recovered.  Information on the lot/batch number of 2nd dose has been requested.; Sender's Comments: The possibility of COVID-19, Vaccination failure being an intercurrent condition cannot be ruled out. The response to the vaccine can vary from one person to another and hence the occurrence of the event post vaccination cannot be completely ruled out.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Eye disorder, Fatigue, Globulin, Haematocrit
Clinical narrative: covid test result Positive; covid test result Positive; joint inflammation; joint inflammation and swelling; extreme hairloss; hemoglobin leakage under skin; intermittent fever; intermittent body rash; extreme itching and/or burning of skin; burning of skin; Fatigue; This is a spontaneous report from a contactable nurse (patient). A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), 1st single dose via an unspecified route of administration in the arm left on 14Jan2021 at 12:15 PM (LOT number: EL3248, expiration date unknown) and 2nd single dose via an unspecified route of administration in the arm left on 10Feb2021 at 12:00 PM (LOT/Batch number and expiration date unknown) for COVID-19 immunization. Patient was 69-year-old at time of vaccination. Patient was not pregnant at time of vaccination and events onset. Medical history included previous breast CA from 1993. Concomitant medications the patient received within 2 weeks of vaccination included losartan, hydrochlorothiazide.  The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. After dose 1, patient had joint inflammation leading to severe joint inflammation and swelling for 12 wks/5 days then extreme hairloss, severe reaction to bee sting and amoxicillin, severe allergic response to foods, histamine and any sugar, hemoglobin leakage under skin, intermittent fever, intermittent body rash, extreme itching and/or burning of skin, fatigue; on 19Jan2021 at 12:00 and were still ongoing. Patient received treatment for above events. Patient had previous covid test (Blood test) on 28Sep2021 which was positive. Test to R/O other things (Blood test) on 28Sep2021 was negative. The events resulted in doctor or other healthcare professional office/clinic visit. "US lower extremities, steroid rash, many visits" was reported as treatment for the events. Outcome of event COVID test result Positive was unknown, of the other events was not recovered.  Information on the lot/batch number of 2nd dose has been requested.; Sender's Comments: The possibility of COVID-19, Vaccination failure being an intercurrent condition cannot be ruled out. The response to the vaccine can vary from one person to another and hence the occurrence of the event post vaccination cannot be completely ruled out.